Procollagen
Research News and Information

Saturday, November 21, 2009

Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone.

25 Oct 2009 OBJECTIVES: This study was designed to evaluate the impact of eplerenone on collagen turnover in preserved systolic function heart failure (HFPSF). BACKGROUND: Despite growing interest in abnormal collagen metabolism as a feature of HFPSF with ... Read more...

Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction.

29 Sep 2009 Acute myocardial infarction (AMI) is associated with matrix metalloproteinase activation. The plasma concentrations of carboxy-terminal telopeptide of collagen type I (CITP) reflect collagen type I degradation due to matrix metalloproteinase ... Read more...

[Biochemical markers of bone turnover. New aspect. Bone metabolic markers in prostatic carcinoma]

30 Jul 2009 Hormonal therapy against prostatic carcinoma brings to osteoporotic change and alendronate is effective to suppress the change. Urinary NTX and serum ICTP are shown to be useful markers to react with hormonal therapy. But most of bone metabolic ... Read more...

Latest indexed articles for 'Procollagen'

These are the very latest articles for this heading:

• Natural history of markers of collagen turnover in patients with early diastolic dysfunction and impact of eplerenone. 25 Oct 2009
• Relation of high concentrations of plasma carboxy-terminal telopeptide of collagen type I with outcome in acute myocardial infarction. 29 Sep 2009
• [Biochemical markers of bone turnover. New aspect. Bone metabolic markers in prostatic carcinoma] 30 Jul 2009
• [Biochemical markers of bone turnover. New aspect. An automated assay for measuring bone turnover markers] 30 Jul 2009
• [Biochemical markers of bone turnover. New aspect. Metabolic bone markers in osteogenesis imperfecta] 30 Jul 2009
• [Biochemical markers of bone turnover. New aspect. Bone metabolic markers available in daily practice] 30 Jul 2009
• TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure. 30 Jul 2009
• Differential gene expression in the perichondrium and cartilage of the neonatal mouse temporomandibular joint. 30 Jul 2009
• Markers of bone destruction and formation and periodontitis in type 1 diabetes mellitus. 30 Jul 2009
• Effect of exogenous hepatocyte growth factor on vocal fold fibroblasts. 30 Jul 2009
• Regenerative effects of basic fibroblast growth factor on extracellular matrix production in aged rat vocal folds. 30 Jul 2009
• Fibronectin binds and enhances the activity of bone morphogenetic protein 1. 16 Jul 2009
• Does exercise modify the effects of zoledronic acid on bone mass, microarchitecture, biomechanics, and turnover in ovariectomized rats? 15 Jul 2009
• Early detection of steatohepatitis in fatty rat liver by using MR elastography. 6 Jul 2009
• Clinical problem-solving. A fragile balance. 30 Jun 2009
• In vivo comparison of biomimetic approaches for tissue regeneration of the scarred vocal fold. 29 Jun 2009
• Levels of biochemical bone marker procollagen type I N-propeptide (PINP) in Thai women aged 40-70 years. 29 Jun 2009
• Bone metabolism in fetuses of pregnant women exposed to single and multiple courses of corticosteroids. 29 Jun 2009
• Effect of oxymatrine on the p38 mitogen-activated protein kinases signalling pathway in rats with CCl4 induced hepatic fibrosis. 18 Jun 2009
• Supplemental calcium attenuates the colitis-related increase in diarrhea, intestinal permeability, and extracellular matrix breakdown in HLA-B27 transgenic rats. 15 Jun 2009

See a longer list of these articles.

Technical information about 'Procollagen'

Definition: A biosynthetic precursor of collagen containing additional amino acid sequences at the amino-terminal and carboxyl-terminal ends of the polypeptide chains.

Registry Number: 0

Descriptor UI: D011347

Alternative terms: Procollagen; Procollagen Type M; Protocollagen;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;

Tree Number: D12.776.811.690; D12.776.860.300.250.600;

History Note: 77

Technical Notes: coord IM with specific collagen (IM) if pertinent